177 related articles for article (PubMed ID: 34265156)
1. Modeling fusion gene-associated sarcoma: Advantages for understanding sarcoma biology and pathology.
Tanaka M; Nakamura T
Pathol Int; 2021 Oct; 71(10):643-654. PubMed ID: 34265156
[TBL] [Abstract][Full Text] [Related]
2. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
[TBL] [Abstract][Full Text] [Related]
3. New fusion sarcomas: histopathology and clinical significance of selected entities.
Miettinen M; Felisiak-Golabek A; Luiña Contreras A; Glod J; Kaplan RN; Killian JK; Lasota J
Hum Pathol; 2019 Apr; 86():57-65. PubMed ID: 30633925
[TBL] [Abstract][Full Text] [Related]
4. [Fusion-related round and spindle cell sarcomas of the bone (beyond Ewing)].
Vanhersecke L; Linck PA; Le Loarer F
Ann Pathol; 2022 Apr; 42(3):227-241. PubMed ID: 35216845
[TBL] [Abstract][Full Text] [Related]
5. Undifferentiated round cell sarcomas with CIC-DUX4 gene fusion: expanding the clinical spectrum.
Brčić I; Brodowicz T; Cerroni L; Kashofer K; Serbanescu GL; Kasseroler MT; Amann G; Scheipl S; Szkandera J; Leithner A; Liegl-Atzwanger B
Pathology; 2020 Feb; 52(2):236-242. PubMed ID: 31870501
[TBL] [Abstract][Full Text] [Related]
6. Small Round Blue Cell Sarcoma Other Than Ewing Sarcoma: What Should an Oncologist Know?
Davis JL; Rudzinski ER
Curr Treat Options Oncol; 2020 Sep; 21(11):90. PubMed ID: 32875423
[TBL] [Abstract][Full Text] [Related]
7. Superficial sarcomas with CIC rearrangement are aggressive neoplasms: A series of eight cases.
Ko JS; Marusic Z; Azzato EM; Farkas DH; Van Arnam J; Seiwerth S; Fritchie K; Patel RM; Rubin BP; Billings SD
J Cutan Pathol; 2020 Jun; 47(6):509-516. PubMed ID: 32026485
[TBL] [Abstract][Full Text] [Related]
8. Novel ATXN1/ATXN1L::NUTM2A fusions identified in aggressive infant sarcomas with gene expression and methylation patterns similar to CIC-rearranged sarcoma.
Xu F; Viaene AN; Ruiz J; Schubert J; Wu J; Chen J; Cao K; Fu W; Bagatell R; Fan Z; Long A; Pagliaroli L; Zhong Y; Luo M; Kreiger PA; Surrey LF; Wertheim GB; Cole KA; Li MM; Santi M; Storm PB
Acta Neuropathol Commun; 2022 Jul; 10(1):102. PubMed ID: 35836290
[TBL] [Abstract][Full Text] [Related]
9. Sarcomas With CIC-rearrangements Are a Distinct Pathologic Entity With Aggressive Outcome: A Clinicopathologic and Molecular Study of 115 Cases.
Antonescu CR; Owosho AA; Zhang L; Chen S; Deniz K; Huryn JM; Kao YC; Huang SC; Singer S; Tap W; Schaefer IM; Fletcher CD
Am J Surg Pathol; 2017 Jul; 41(7):941-949. PubMed ID: 28346326
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma.
Zhu G; Benayed R; Ho C; Mullaney K; Sukhadia P; Rios K; Berry R; Rubin BP; Nafa K; Wang L; Klimstra DS; Ladanyi M; Hameed MR
Mod Pathol; 2019 May; 32(5):609-620. PubMed ID: 30459475
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel MTAP-RAF1 fusion in a soft tissue sarcoma.
Hicks JK; Henderson-Jackson E; Duggan J; Joyce DM; Brohl AS
Diagn Pathol; 2018 Oct; 13(1):77. PubMed ID: 30314519
[TBL] [Abstract][Full Text] [Related]
12.
Yoshimoto T; Tanaka M; Homme M; Yamazaki Y; Takazawa Y; Antonescu CR; Nakamura T
Cancer Res; 2017 Jun; 77(11):2927-2937. PubMed ID: 28404587
[No Abstract] [Full Text] [Related]
13. Targeting the undruggable: exploiting neomorphic features of fusion oncoproteins in childhood sarcomas for innovative therapies.
Knott MML; Hölting TLB; Ohmura S; Kirchner T; Cidre-Aranaz F; Grünewald TGP
Cancer Metastasis Rev; 2019 Dec; 38(4):625-642. PubMed ID: 31970591
[TBL] [Abstract][Full Text] [Related]
14. The clinical heterogeneity of round cell sarcomas with EWSR1/FUS gene fusions: Impact of gene fusion type on clinical features and outcome.
Tsuda Y; Zhang L; Meyers P; Tap WD; Healey JH; Antonescu CR
Genes Chromosomes Cancer; 2020 Sep; 59(9):525-534. PubMed ID: 32362012
[TBL] [Abstract][Full Text] [Related]
15. KMT2A (MLL) fusions in aggressive sarcomas in young adults.
Yoshida A; Arai Y; Tanzawa Y; Wakai S; Hama N; Kawai A; Shibata T
Histopathology; 2019 Oct; 75(4):508-516. PubMed ID: 31136005
[TBL] [Abstract][Full Text] [Related]
16. CIC-DUX4 fusion-positive round-cell sarcomas of soft tissue and bone: a single-institution morphological and molecular analysis of seven cases.
Gambarotti M; Benini S; Gamberi G; Cocchi S; Palmerini E; Sbaraglia M; Donati D; Picci P; Vanel D; Ferrari S; Righi A; Dei Tos AP
Histopathology; 2016 Oct; 69(4):624-34. PubMed ID: 27079694
[TBL] [Abstract][Full Text] [Related]
17. Important Recently Characterized Non-Ewing Small Round Cell Tumors.
Carter CS; Patel RM
Surg Pathol Clin; 2019 Mar; 12(1):191-215. PubMed ID: 30709443
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of synovial sarcoma with the reverse transcriptase-polymerase chain reaction: analyses of 84 soft tissue and bone tumors.
Hiraga H; Nojima T; Abe S; Sawa H; Yamashiro K; Yamawaki S; Kaneda K; Nagashima K
Diagn Mol Pathol; 1998 Apr; 7(2):102-10. PubMed ID: 9785009
[TBL] [Abstract][Full Text] [Related]
19. Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma.
Carrabotta M; Laginestra MA; Durante G; Mancarella C; Landuzzi L; Parra A; Ruzzi F; Toracchio L; De Feo A; Giusti V; Pasello M; Righi A; Lollini PL; Palmerini E; Donati DM; Manara MC; Scotlandi K
Cancer Res; 2022 Feb; 82(4):708-720. PubMed ID: 34903601
[TBL] [Abstract][Full Text] [Related]
20. A t(4;19) pediatric undifferentiated sarcoma with a novel variant of the CIC-DUX4 fusion transcript.
Krskova L; Stejskalova E; Kabickova E; Mrhalova M; Kodet R
Pathol Res Pract; 2017 Mar; 213(3):281-285. PubMed ID: 28062084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
